This is definitely one of my favorite threads. Keep it up, guys! Phamaceuticals anyone? Seems like Schering-Plough (SGP) is doing pretty well compared to Pfizer (PFE), Eli Lily (LLY), Bristo-Myers Squibb (BMY) and even Novartis (NVS). What do you guys think? Care impart any wisdom on this sector?